378 related articles for article (PubMed ID: 17094096)
1. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
Fung EB; Harmatz PR; Lee PD; Milet M; Bellevue R; Jeng MR; Kalinyak KA; Hudes M; Bhatia S; Vichinsky EP;
Br J Haematol; 2006 Nov; 135(4):574-82. PubMed ID: 17054676
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
[TBL] [Abstract][Full Text] [Related]
4. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
5. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
6. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.
Fung EB; Harmatz PR; Milet M; Balasa V; Ballas SK; Casella JF; Hilliard L; Kutlar A; McClain KL; Olivieri NF; Porter JB; Vichinsky EP;
Transfusion; 2008 Sep; 48(9):1971-80. PubMed ID: 18513257
[TBL] [Abstract][Full Text] [Related]
7. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
8. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
9. [Iron overload in sickle cell anemia : a study of 94 patients].
Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
[TBL] [Abstract][Full Text] [Related]
10. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.
Vichinsky E; Butensky E; Fung E; Hudes M; Theil E; Ferrell L; Williams R; Louie L; Lee PD; Harmatz P
Am J Hematol; 2005 Sep; 80(1):70-4. PubMed ID: 16138345
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
12. Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.
Kaushik N; Eckrich MJ; Parra D; Yang E
Pediatr Hematol Oncol; 2012 Apr; 29(3):254-60. PubMed ID: 22303979
[TBL] [Abstract][Full Text] [Related]
13. Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.
Fung EB; Harmatz PR; Milet M; Coates TD; Thompson AA; Ranalli M; Mignaca R; Scher C; Giardina P; Robertson S; Neumayr L; Vichinsky EP;
Bone; 2008 Jul; 43(1):162-168. PubMed ID: 18430624
[TBL] [Abstract][Full Text] [Related]
14. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
15. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
Ballas SK
Semin Hematol; 2001 Jan; 38(1 Suppl 1):30-6. PubMed ID: 11206959
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
[TBL] [Abstract][Full Text] [Related]
18. Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.
Pack-Mabien A; Brown B; Herbert DE; Haynes J
J Am Assoc Nurse Pract; 2015 Oct; 27(10):591-6. PubMed ID: 25711464
[TBL] [Abstract][Full Text] [Related]
19. Consequences and management of iron overload in sickle cell disease.
Porter J; Garbowski M
Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
[TBL] [Abstract][Full Text] [Related]
20. Iron overload in hematopoietic cell transplantation.
Majhail NS; Lazarus HM; Burns LJ
Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]